Anaesthesia and orphan disease series: What is the yield?

    loading  Checking for direct PDF access through Ovid


In April 2011, the Editorial board of the European Journal of Anaesthesiology decided to offer clinicians the opportunity of publishing case reports on the anaesthetic management of patients with rare diseases as Letters to the Editor. This special series was called ‘Anaesthesia and orphan disease’.1 It was launched at the same time as the Germany-driven OrphanAnaesthesia project.2 This decision was made at the time when all the major journals, including the European Journal of Anaesthesiology, had decided to reduce or even cease the publication of case reports. This decision was taken because the scientific value of case reports varies greatly3 and also because case reports are rarely quoted. This latter fact has a negative effect on the journal impact factor. On the other hand, case reports can convey useful clinical messages and, after all, we all like reading short clinical stories because they present us with challenging situations. Consequently, several journals have reintroduced some types of case reports (e.g. images sections),4 and even new journals have been created, for example, A&A Case Reports.
Coming back to the Anaesthesia and orphan disease series in the European Journal of Anaesthesiology, 55 manuscripts were submitted up to November 2016 out of which 30 were published. Their categorisation according to the nature of the disease and the population concerned is shown in Table 1. The main issues described in the published papers were: difficult intubation (n = 9),5 use of muscle relaxants and their reversal (n = 3),6 regional anaesthesia (n = 3)7 or possible interactions with the patient's medical treatment (n = 2).8,9 Three papers were the first description of the anaesthetic management of a patient with the described disease.10–12 Surprisingly, although in comparison to research manuscripts, case reports are usually considered as ‘easy’ papers to write, most published case reports required three peer review processes, with rewriting after each (not taking into account final language editing which could also involve some peer review), before being accepted.
Regarding the manuscripts which were not published, there were four main reasons for their rejection. First, lack of new information. Some rare diseases have already been reported in the anaesthetic literature and no original or useful contribution was found in the submitted manuscript. Second, poor description of the case; the diagnosis of the disease was not well established (e.g. genetics, electromyography or histology in the case of muscle disease etc.) and/or the anaesthetic management was not described in enough detail (drugs and dosage, monitoring and so on). Third, discrepancy between the authors’ recommendations and the actual management. For example, in one case, preoperative echocardiography was recommended on the basis of the disease pathophysiology but none was performed. This is not acceptable, unless the disease was unsuspected and uncovered only following a perianaesthetic haemodynamic complication. And finally, although rarely, when clinical management was considered to be verging on poor practice. For example, authors, without any supporting evidence, recommended the administration of a hypotonic i.v. solution as a maintenance fluid, or the use of muscle relaxants without monitoring the adequacy or recovery of the neuromuscular blockade. The submitted manuscripts need to have some educational value, and publishing bad practice could be interpreted as approving its use by the editors.
I take this opportunity to thank the reviewers who participated in the evaluation of all the manuscripts. Their opinions, whether targeted at the described disorder because of their expertise, or based on their clinical experience, were of great value, and often helped the authors improve the content and presentation of their manuscript.
I hope that the information above will encourage even more colleagues to publish in our journal, sharing their experiences of the perianaesthetic care of patients with rare diseases.
    loading  Loading Related Articles